(PharmaNewsWire.Com, June 26, 2019 ) As per the latest report by IMARC Group, titled “Global Dermal Facial Fillers Market Report and Forecast 2019-2024”, the global dermal facial fillers market reached a value of US$ 2.3 Billion in 2018, growing at a CAGR of 11.35% during 2011-2018. Dermal facial fillers are natural or synthetic injectable solutions which aid in restoring the smooth appearance of the skin by reducing facial wrinkles and combating other signs of aging such as fine lines and spots. Containing collagen, hyaluronic acid and calcium hydroxylapatite, these fillers are also adopted by users for raising scar depressions, enhancing lips and replacing soft-tissue volume loss. The effectiveness of dermal fillers depends on various factors such as the product used in the procedure and the area treated.
A significant increase in the number of people seeking treatment for facial wrinkles and scarring is one of the key factors driving the market growth. Lifestyle habits such as smoking and excessive alcohol consumption lead to the early aging of the skin. This has led people to seek recourse which aids in retaining their youthful appearance by preventing early skin sagging and wrinkling. Moreover, since dermal facial fillers are non-invasively injected, they involve quick recovery and negligible post-surgery complications, and hence are gaining rapid popularity among the masses. Furthermore, the increasing popularity of image-centric social media platforms like Instagram, YouTube and Facebook has given rise to appearance-related anxiety among the users. This has led them to improve their appearance by adopting various medical procedures such as dermal facial fillers, primarily as a pre-aging measure. Owing to the aforementioned factors, the market is expected to reach a value of US$ 4.2 Billion by 2024, exhibiting a CAGR of around 10.4% during 2019-2024.
Based on the material type, the market has been divided into temporary, semi-permanent and permanent fillers. Amongst these, temporary fillers currently dominate the market.
On the basis of the product origin, the market has been bifurcated into natural and synthetic segments. Currently, the natural segment accounts for the majority of the total global market.
On the geographical front, North America holds the leading position in the market. Other major regions include Europe, Asia Pacific, Middle East and Africa, and Latin America.
The competitive landscape of the market has also been studied with some of the key players operating in the market being Allergan, Galderma, Merz Pharma, AQTIS Medical, Bioha Laboratories, Cynosure, Cosmoderm, ColBar LifeScience, Techderm, Regenerative Medical System, Suneva Medical, Sanofi, SciVision Biotech, Speciality European Pharma, Syneron, Ulthera and Visionmed.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
